Clinical Trial Update: Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 1/2 study evaluating zoledronate (Zometa) in giant cell tumor of bone, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Nantes University Hospital | Conditions: Giant Cell Tumors of Bone | Phase 1, Phase 2 | Status: TERMINATED